Mass Spectrometry & Proteomics news

<p>Marta Vilaseca, IRB Barcelona</p>
17 Abr 2018

La sèrie Meet Our Scientists presenta a Marta Vilaseca, directora de la Plataforma Científica d'Espectrometria de Masses i Proteòmica de l'IRB Barcelona.

El vídeo "Proteins caught in fraganti" (Proteïnes pescades in fraganti) presenta l'àrea de treball de la científica.

<p>Illustrative image of how scientists have deciphered the covalent nature of beta-amyloid dimers, an article published in Analytical Chemistry. Authors: Marina Gay, IRB Barcelona, and Lorena Markovich</p>
17 Abr 2018

Un treball liderat a l’IRB Barcelona aporta la primera evidència directa de dímers (unió de dues proteïnes) de beta-amiloide en malalts d’Alzheimer i els assenyala com a potencial biomarcador.

Els dímers de beta-amiloide podrien ser l’espècie patològica més petita que desencadenés la malaltia d’Alzheimer.

<p>From right to left: Marina Gay, Marta Vilaseca, Mar Vilanova, Laura Villareal, Mireia Díaz-Lobo.</p>
27 Mai 2016

IRB Barcelona steps into High-Throughput Proteomics. After passing an external evaluation, the Mass Spectrometry Core Facility has been renamed “Mass Spectrometry and Proteomics Core Facility”. Its mission is “to apply advanced proteomic methods to help researchers study diseases, pathways, targets and drugs effects,” says Core Facility manager Marta Vilaseca, who emphasises the contribution of her team to cutting-edge research at the Institute.

The facility has recently been enlarged and now occupies an additional area in the PCB to host a new Orbitrap Fusion Lumos, which has just been installed and is fully...